AtaiBeckley (ATAI) Return on Sales (2021 - 2026)

AtaiBeckley (ATAI) recorded quarterly Return on Sales of 0.31% in Q1 2026, down 84.66% quarter-over-quarter from 0.17% in Q1 2025, and down 14.0% on a YoY basis from 0.37% in Q1 2025.

AtaiBeckley (ATAI) Return on Sales (2021 - 2026) Analysis & Trends

AtaiBeckley has disclosed Return on Sales across 5 years of filings, most recently posting 0.82% for Q3 2025.

  • Return on Sales for Q3 2025 came in at 0.82%, up 576.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.51% (up 329.0% YoY), and the FY2024 annual result was 4.83%, down 361.0% from the prior year.
  • Return on Sales was 0.31% for Q1 2026 at AtaiBeckley, down from 0.17% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.17% in Q1 2025 to a low of 0.31% in Q1 2026.
  • The 5-year median for Return on Sales is 1.85% (2023), against an average of 4.93%.
  • Across the five-year window, Return on Sales soared 1887 bps in 2023 and tumbled 2350 bps in 2024, its largest moves.
  • AtaiBeckley's Return on Sales stood at 2.27% in 2021, then tumbled by 426 bps to 11.93% in 2022, then climbed by 22 bps to 9.29% in 2023, then tumbled by 253 bps to 32.78% in 2024, then surged by 98 bps to 0.82% in 2025.
  • The last three Return on Sales figures came in at 0.82% (Q3 2025), 0.39% (Q2 2025), and 0.17% (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 AtaiBeckley 1.45 Bn 1.45 Bn - -0.31%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.31%
Sep 30, 2025 -0.82%
Jun 30, 2025 -0.39%
Mar 31, 2025 -0.17%
Mar 31, 2025 -0.17%
Dec 31, 2024 -32.78%
Sep 30, 2024 -6.57%
Jun 30, 2024 -2.09%
Mar 31, 2024 -1.11%
Dec 31, 2023 -9.29%
Sep 30, 2023 5.01%
Jun 30, 2023 -1.85%
Mar 31, 2023 -9.02%
Dec 31, 2022 -11.93%
Sep 30, 2022 -13.86%
Jun 30, 2022 -1.82%
Mar 31, 2022 -3.60%
Dec 31, 2021 -2.27%
Sep 30, 2021 -1.01%
Jun 30, 2021 -0.09%